A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
Crossref DOI link: https://doi.org/10.1186/s13075-015-0718-y
Published Online: 2015-08-22
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murakami, Masato
Osada, Kenichi
Mizuno, Hiromichi
Ochiai, Toshimitsu
Alev, Levent
Nishioka, Kusuki